Walleye Capital’s RenovoRx RNXT Stock Holding History

Walleye Capital’s Portfolio RNXT Stock Details RNXT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$409K	Buy	+262,106	New	+$350K	﹤0.01%	4240

Other funds holding RNXT

ACM

AIGH Capital Management Baltimore, Maryland $992M AUM 516.32% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

Bleichroeder LP New York $1.02B AUM 33% 1-Year Est. Return

Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $463B AUM

Wealthspire Advisors (New York) New York $17.6B AUM 14.61% 1-Year Est. Return

SEI Investments Oaks, Pennsylvania $113B AUM 26.61% 1-Year Est. Return

Jane Street New York $1.19T AUM 51.51% 1-Year Est. Return

Walleye Capital's RNXT Position: Q3 2026 in Review

Walleye Capital opened a new position in RenovoRx (RNXT) in Q3 2026: 262,106 shares worth $409K. The stake represents ﹤0.01% of the portfolio and ranks #4240 among its holdings.

30 funds tracked by Wall St. Rank hold RNXT as of Q3 2026.

Walleye Capital held 262,106 shares of RenovoRx worth $409K as of Q3 2026.
RenovoRx was a new Walleye Capital position in Q3 2026.
RenovoRx made up ﹤0.01% of Walleye Capital's portfolio in Q3 2026, its #4240 holding.
30 funds tracked by Wall St. Rank held RenovoRx as of Q3 2026.

Based on Walleye Capital's 13F filing for Q3 2026, filed 13 Nov 2026.